Works in Cardiovascular Drugs & Therapy, 2024, Vol 38, Issue 5

Results: 22

Use of Early Intravenous Beta Blockers in Patients with Acute ST-Segment Elevation Myocardial Infarction Without Heart Failure—Revival or Requiem?

Published in:

Cardiovascular Drugs & Therapy, 2024, v. 38, n. 5, p. 973, doi. 10.1007/s10557-024-07626-5

By:

Latif, Azka;
Jia, Xiaoming

Publication type:

Article

Flow Matters: Optimizing Invasive Coronary Physiology to Improve Long-Term Outcomes.

Published in:

Cardiovascular Drugs & Therapy, 2024, v. 38, n. 5, p. 971, doi. 10.1007/s10557-024-07617-6

By:

Chaus, Adib;
Uretsky, Barry F.

Publication type:

Article

Levosimendan for Diastolic Dysfunction?

Published in:

Cardiovascular Drugs & Therapy, 2024, v. 38, n. 5, p. 1053, doi. 10.1007/s10557-024-07606-9

By:

Birnbaum, Yochai;
McClendon, Lisa Kay

Publication type:

Article

Retraction Note: Differential Expression of LOXL1-AS1 in Coronary Heart Disease and Its Regulatory Mechanism in ox-LDL-Induced Human Coronary Artery Endothelial Cell Pyroptosis.

Published in:

2024

By:

Song, Bangrong;
Dang, Haiming;
Dong, Ran

Publication type:

Correction Notice

Insulin Resistance Triggers Atherosclerosis: Caveolin 1 Cooperates with PKCzeta to Block Insulin Signaling in Vascular Endothelial Cells.

Published in:

Cardiovascular Drugs & Therapy, 2024, v. 38, n. 5, p. 885, doi. 10.1007/s10557-023-07477-6

By:

Tan, Jingjing;
Li, Xiaoguang;
Dou, Ning

Publication type:

Article

Research progress on the therapeutic effects of nanoparticles loaded with drugs against atherosclerosis.

Published in:

Cardiovascular Drugs & Therapy, 2024, v. 38, n. 5, p. 977, doi. 10.1007/s10557-023-07461-0

By:

Shi, Tianfeng;
Liu, Kunkun;
Peng, Yueyou;
Dai, Weibin;
Du, Donglian;
Li, Xiaoqiong;
Liu, Tingting;
Song, Ningning;
Meng, Yanfeng

Publication type:

Article

Complex Interplay Between Metabolism and CD4<sup>+</sup> T-Cell Activation, Differentiation, and Function: a Novel Perspective for Atherosclerosis Immunotherapy.

Published in:

Cardiovascular Drugs & Therapy, 2024, v. 38, n. 5, p. 1033, doi. 10.1007/s10557-023-07466-9

By:

Yang, Jingmin;
Chen, Yanying;
Li, Xiao;
Qin, Huali;
Bao, Jinghui;
Wang, Chunfang;
Dong, Xiaochen;
Xu, Danyan

Publication type:

Article

Acute and Post-Acute COVID-19 Cardiovascular Complications: A Comprehensive Review.

Published in:

Cardiovascular Drugs & Therapy, 2024, v. 38, n. 5, p. 1017, doi. 10.1007/s10557-023-07465-w

By:

Kole, Christo;
Stefanou, Εleni;
Karvelas, Nikolaos;
Schizas, Dimitrios;
Toutouzas, Konstantinos P.

Publication type:

Article

Regulatory T Cells in Pathological Cardiac Hypertrophy: Mechanisms and Therapeutic Potential.

Published in:

Cardiovascular Drugs & Therapy, 2024, v. 38, n. 5, p. 999, doi. 10.1007/s10557-023-07463-y

By:

Liu, Leiling;
Hu, Jiahui;
Lei, Hao;
Qin, Huali;
Wang, Chunfang;
Gui, Yajun;
Xu, Danyan

Publication type:

Article

Effect of Prolonged Use of Dronedarone on Recurrence in Patients with Non-Paroxysmal Atrial Fibrillation After Radiofrequency Ablation (DORIS): Rationale and Design of a Randomized Multicenter, Double-Blinded Placebo-Controlled Trial.

Published in:

Cardiovascular Drugs & Therapy, 2024, v. 38, n. 5, p. 1047, doi. 10.1007/s10557-023-07460-1

By:

Wu, Yizhang;
Fan, Fenghua;
Yu, Jinbo;
Zhou, Jian;
Xie, Xin;
Xia, Guang;
Zhong, Dongxiang;
Cheng, Dian;
Zhang, Baowei;
Wang, Xuecheng;
Chen, Zijun;
Wang, Shuo;
Li, Xiaorong;
Yang, Bing

Publication type:

Article

Rivaroxaban in Valvular Atrial Fibrillation — a Critical Appraisal of the INVICTUS Trial.

Published in:

Cardiovascular Drugs & Therapy, 2024, v. 38, n. 5, p. 1065, doi. 10.1007/s10557-023-07470-z

By:

Hammer, Andreas;
Niessner, Alexander;
Sulzgruber, Patrick

Publication type:

Article

Glucagon-Like Peptide-1 Inhibits the Progression of Abdominal Aortic Aneurysm in Mice: The Earlier, the Better.

Published in:

Cardiovascular Drugs & Therapy, 2024, v. 38, n. 5, p. 873, doi. 10.1007/s10557-023-07456-x

By:

Zhao, Xinghan;
Cheng, Zhang;
Zhang, Hongbo;
Guo, Yingkun;
Zhao, Lei;
Zhang, Chen;
Ye, Pengfei;
Zhang, Kun;
Ma, Xiaohai;
Wu, Qihong

Publication type:

Article

The Impact of Convertase Subtilisin/Kexin Type 9 Monoclonal Antibodies with and without Apheresis on Platelet Aggregation in Familial Hypercholesterolemia.

Published in:

Cardiovascular Drugs & Therapy, 2024, v. 38, n. 5, p. 959, doi. 10.1007/s10557-023-07455-y

By:

Konečný, Lukáš;
Hrubša, Marcel;
Karlíčková, Jana;
Carazo, Alejandro;
Javorská, Lenka;
Matoušová, Kateřina;
Krčmová, Lenka Kujovská;
Blaha, Vladimír;
Bláha, Milan;
Mladěnka, Přemysl

Publication type:

Article

Impact of Low-Dose Prasugrel on Platelet Reactivity in Chronic Phase of Post-Percutaneous Coronary Intervention (CHAPERON): a Prospective Cohort Study.

Published in:

Cardiovascular Drugs & Therapy, 2024, v. 38, n. 5, p. 947, doi. 10.1007/s10557-023-07454-z

By:

Fukase, Tatsuya;
Doi, Shinichiro;
Dohi, Tomotaka;
Koike, Takuma;
Nishio, Ryota;
Yasuda, Hidetoshi;
Takeuchi, Mitsuhiro;
Takahashi, Norihito;
Chikata, Yuichi;
Endo, Hirohisa;
Nishiyama, Hiroki;
Okai, Iwao;
Iwata, Hiroshi;
Okazaki, Shinya;
Daida, Hiroyuki;
Suwa, Satoru;
Minamino, Tohru;
Miyauchi, Katsumi

Publication type:

Article

Recurrent Atherosclerotic Cardiovascular Disease Events Potentially Prevented with Guideline-Recommended Cholesterol-Lowering Therapy following Myocardial Infarction.

Published in:

Cardiovascular Drugs & Therapy, 2024, v. 38, n. 5, p. 937, doi. 10.1007/s10557-023-07452-1

By:

Sakhuja, Swati;
Bittner, Vera A.;
Brown, Todd M.;
Farkouh, Michael E.;
Levitan, Emily B.;
Safford, Monika M.;
Woodward, Mark;
Chen, Ligong;
Sun, Ruoyan;
Dhalwani, Nafeesa;
Jones, Jenna;
Kalich, Bethany;
Exter, Jason;
Muntner, Paul;
Rosenson, Robert S.;
Colantonio, Lisandro D.

Publication type:

Article

Direct Oral Anticoagulants in Patients with Atrial Fibrillation and Significant Mitral Stenosis—a Preliminary Meta-Analysis.

Published in:

Cardiovascular Drugs & Therapy, 2024, v. 38, n. 5, p. 1059, doi. 10.1007/s10557-023-07451-2

By:

Zhang, Yi;
Chen, Mao

Publication type:

Article

Epigallocatechin-3-Gallate Inhibits Atrial Fibrosis and Reduces the Occurrence and Maintenance of Atrial Fibrillation and its Possible Mechanisms.

Published in:

Cardiovascular Drugs & Therapy, 2024, v. 38, n. 5, p. 895, doi. 10.1007/s10557-023-07447-y

By:

Li, Tao;
Tong, Qi;
Wang, Zhengjie;
Yang, Ziqi;
Sun, Yiren;
Cai, Jie;
Xu, Qiyue;
Lu, Yuan;
Liu, Xuemei;
Lin, Ke;
Qian, Yongjun

Publication type:

Article

Meta-Analysis Evaluating Risk of Hyperkalemia Stratified by Baseline MRA Usage in Patients with Heart Failure Receiving SGLT2 Inhibitors.

Published in:

Cardiovascular Drugs & Therapy, 2024, v. 38, n. 5, p. 1055, doi. 10.1007/s10557-023-07446-z

By:

Ahmed, Aymen;
Ahmed, Warda;
Arshad, Muhammad Sameer;
Suri, Azeema;
Amin, Emaan;
Shahid, Izza;
Memon, Muhammad Mustafa

Publication type:

Article

Pharmacological Inhibition of P-Rex1/Rac1 Axis Blocked Angiotensin II-Induced Cardiac Fibrosis.

Published in:

Cardiovascular Drugs & Therapy, 2024, v. 38, n. 5, p. 861, doi. 10.1007/s10557-023-07442-3

By:

Pan, Jianyuan;
Liu, Ming;
Su, Huimin;
Hu, Hao;
Chen, Hongwu;
Ma, Likun

Publication type:

Article

Left Bundle Branch Pacing for Bradycardia in Non-obstructive Hypertrophic Cardiomyopathy Patients: Feasibility, Safety, and Effect.

Published in:

Cardiovascular Drugs & Therapy, 2024, v. 38, n. 5, p. 927, doi. 10.1007/s10557-023-07440-5

By:

Yang, Wen;
Wu, Tian;
Wu, Yixian;
Xu, Jiayi;
Jiang, Zhixin;
Zhou, Xiujuan;
Shan, Qijun

Publication type:

Article

Clinical Implications of Fractional Flow Reserve Measured Immediately After Percutaneous Coronary Intervention.

Published in:

Cardiovascular Drugs & Therapy, 2024, v. 38, n. 5, p. 917, doi. 10.1007/s10557-023-07437-0

By:

Csanádi, Bettina;
Ferenci, Tamás;
Fülöp, Gábor;
Piróth, Zsolt

Publication type:

Article

Correction to: Polygenic Risk Score: Clinically Useful Tool for Prediction of Cardiovascular Disease and Benefit from Lipid-Lowering Therapy?

Published in:

2024

By:

Arnold, Natalie;
Koenig, Wolfgang

Publication type:

Correction Notice